Profile | GDS2987 / GI_30581119-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 471.6 | 91 |
GSM215244 | HMVEC_vehicle_rep2 | 730.1 | 93 |
GSM215253 | HMVEC_vehicle_rep3 | 557 | 92 |
GSM215254 | HMVEC_atorvastatin_rep1 | 1006.6 | 95 |
GSM215282 | HMVEC_atorvastatin_rep3 | 1111 | 95 |
GSM215344 | HMVEC_atorvastatin_rep2 | 1209.1 | 95 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 729.9 | 93 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 648.2 | 92 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 705.4 | 92 |
GSM215294 | HMVEC_SLx2119_rep1 | 365.9 | 89 |
GSM215295 | HMVEC_SLx2119_rep2 | 358 | 87 |
GSM215296 | HMVEC_SLx2119_rep3 | 368.7 | 87 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 1.3 | 2 |
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 16.7 | 32 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | 22.2 | 37 |
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | 7.6 | 15 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | 8.3 | 24 |
GSM215332 | Fibroblasts_vehicle_rep3 | 6.3 | 22 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | ||
GSM215334 | Fibroblasts_atorvastatin_rep2 | 9.3 | 26 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 17 | 39 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 3.8 | 13 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 6.3 | 21 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | ||
GSM215339 | Fibroblasts_SLx2119_rep1 | 4.4 | 13 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 13.5 | 36 |
GSM215341 | Fibroblasts_SLx2119_rep3 |